Chronic myeloid leukemia: past, present, future

Chronic myeloid leukemia: past, present, future

Show other versions (1)

The discovery of the Philadelphia chromosome in 1960, and of theBCR-ABL oncogene in 1984, enabled the development in subsequentyears of a targeted therapy that revolutionized the treatment of chronic myeloid leukemia, thus changing its natural history. The use of imatinib resulted in a significant i...

Full description

Bibliographic Details
Main Authors: Patricia Weinschenker Bollmann, Auro del Giglio
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2011-06-01
Series:Einstein (São Paulo)
Subjects:
Leukemia
myelogenous
chronic
BCR-ABL positive / therapy
Protein kinase inhibitors/therapeutic use
Drug resistance
Online Access:http://apps.einstein.br/revista/arquivos/PDF/2022-Einstein_v9n2_236-243.pdf

Internet

http://apps.einstein.br/revista/arquivos/PDF/2022-Einstein_v9n2_236-243.pdf

Similar Items